Sterol carrier protein 2 Antibody (24GB790)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-50561
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Rabbit IgG Clone # 24GB790
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthesized peptide derived from human Sterol carrier protein 2 (Uniprot: P22307)
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Sterol carrier protein 2 Antibody (24GB790)
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.4), 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Sterol carrier protein 2
Alternate Names
DKFZp686C12188, DKFZp686D11188, NLTP, non-specific lipid-transfer protein, NSL-TP, Propanoyl-CoA C-acyltransferase, SCP-2, SCP-chi, SCPX, SCP-X, sterol carrier protein 2EC 2.3.1.176, Sterol carrier protein X
Gene Symbol
SCP2
Additional Sterol carrier protein 2 Products
Product Documents for Sterol carrier protein 2 Antibody (24GB790)
Product Specific Notices for Sterol carrier protein 2 Antibody (24GB790)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...